NATIXIS – Edwards Lifesciences Corporation Transaction History
NATIXIS portfolio value:
$13.08M
portfolio value
NATIXIS quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +210.33% | 106.12K shares | 8.28M | $82.63 | 156.57K |
| Q2 2022 | share | Decrease | -45.53% | -42.18K shares | -6.10M | $95.09 | 50.45K |
| Q1 2022 | share | Increase | +357.75% | 72.39K shares | 8.28M | $117.72 | 92.63K |
| Q4 2021 | share | Decrease | -32.36% | -9.68K shares | -765K | $130.68 | 20.23K |
| Q3 2021 | share | Decrease | -25.57% | -10.27K shares | -776K | $113.21 | 29.91K |
| Q2 2021 | share | Decrease | -65.32% | -75.72K shares | -5.53M | $103.57 | 40.19K |
| Q1 2021 | share | Decrease | -6.58% | -8.17K shares | -1.62M | $83.64 | 115.91K |
| Q4 2020 | share | Increase | 0.00% | 124.08K shares | 11.32M | $91.23 | 124.08K |
| Q3 2020 | share | Decrease | -100.00% | -22.37K shares | -1.54M | $79.82 | 0 |
| Q2 2020 | share | Decrease | -81.82% | -100.71K shares | -6.19M | $69.11 | 22.37K |
| Q1 2020 | share | Increase | +138.80% | 71.54K shares | 3.74M | $62.87 | 123.09K |
| Q4 2019 | share | Decrease | -77.66% | -179.14K shares | -12.91M | $77.76 | 51.54K |
| Q3 2019 | share | Increase | 0.00% | 230.69K shares | 16.91M | $73.3 | 230.69K |
| Q3 2018 | share | Decrease | -100.00% | -102.70K shares | -4.98M | $58.03 | 0 |
| Q2 2018 | share | Decrease | -8.58% | -9.63K shares | -240K | $48.52 | 102.70K |
| Q1 2018 | share | Increase | +138.31% | 65.19K shares | 3.45M | $46.51 | 112.33K |
| Q4 2017 | share | Decrease | -52.53% | -52.17K shares | -1.84M | $37.57 | 47.13K |
| Q3 2017 | share | Increase | 0.00% | 99.31K shares | 3.61M | $36.44 | 99.31K |
| Q2 2017 | share | Decrease | -100.00% | -13.12K shares | -412K | $39.41 | 0 |
| Q1 2017 | share | Increase | 0.00% | 13.12K shares | 412K | $31.36 | 13.12K |